1999
DOI: 10.1677/joe.0.1620381
|View full text |Cite
|
Sign up to set email alerts
|

Glucocorticoid and mineralocorticoid regulation of angiotensin II type 1 receptor binding and inositol triphosphate formation in WB cells

Abstract: Mineralocorticoids, glucocorticoids, and angiotensin II (AngII) act cooperatively to maintain body fluid homeostasis. Mineralocorticoids, such as aldosterone and deoxycorticosterone-acetate (DOCA), function synergistically with AngII in the brain to increase salt appetite and blood pressure. In addition, glucocorticoids increase AngII-induced drinking and pressor responses and may also facilitate the actions of aldosterone on salt appetite. The AngII Type 1 (AT1) receptor mediates many of the physiological and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
1

Year Published

2005
2005
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(19 citation statements)
references
References 62 publications
0
18
1
Order By: Relevance
“…Thus the "synergy" hypothesis of salt appetite (4, 7) now includes prominent roles for glucocorticoids and their receptors (6,8). In the brain, glucocorticoids increase ANG II receptor binding while amplifying ANG II-related intracellular signaling processes (3,6,(22)(23)(24)27) and also increase binding to type I mineralocorticoid receptors (8,17,35). Dex in combination with DOCA increases ANG II binding at angiotensin type 1 (AT 1 ) receptors in brain areas involved in mediating responses to circulating ANG II, including the subfornical organ, area postrema, and paraventricular nucleus (22).…”
Section: Discussionmentioning
confidence: 99%
“…Thus the "synergy" hypothesis of salt appetite (4, 7) now includes prominent roles for glucocorticoids and their receptors (6,8). In the brain, glucocorticoids increase ANG II receptor binding while amplifying ANG II-related intracellular signaling processes (3,6,(22)(23)(24)27) and also increase binding to type I mineralocorticoid receptors (8,17,35). Dex in combination with DOCA increases ANG II binding at angiotensin type 1 (AT 1 ) receptors in brain areas involved in mediating responses to circulating ANG II, including the subfornical organ, area postrema, and paraventricular nucleus (22).…”
Section: Discussionmentioning
confidence: 99%
“…Mineralocorticoids have further been shown to upregulate Fos (41,42), angiotensin receptors (51), oxytocin receptors (51), vasopressin (20), and the vasopressin V 1a receptor (41,42). Vasopressin (11) and angiotensin II (9,29,45,50,51) in turn stimulate, whereas oxytocin (53) inhibits, salt intake. Interestingly, the effect of mineralocorticoids or salt depletion on salt appetite may be modified by glucocorticoids (18,34,50) and amphetamine (5).…”
Section: Discussionmentioning
confidence: 99%
“…Vasopressin (11) and angiotensin II (9,29,45,50,51) in turn stimulate, whereas oxytocin (53) inhibits, salt intake. Interestingly, the effect of mineralocorticoids or salt depletion on salt appetite may be modified by glucocorticoids (18,34,50) and amphetamine (5). Moreover, salt appetite has been shown to be dependent on the age of the animal (54).…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, rats treated with DOC and dexamethasone consumed more NaCl than when given DOC alone. Furthermore, co-administration of DOC and dexamethasone increased angiotensin II receptor binding in the paraventricular nucleus, subfornical organ and area postrema, but administration of only DOC had no such effect (Shelat et al, 1999a). Accordingly, new models of hormonal regulation of salt appetite incorporate the contributions of mineralcorticoids as well as glucocorticoids.…”
Section: Central Interactions Of Aldosterone and Angiotensin IImentioning
confidence: 99%